During the past decade, Istanbul Universitesi Onkoloji Enstitusu conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul Universitesi Onkoloji Enstitusu" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Istanbul Universitesi Onkoloji Enstitusu" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Head and Neck Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Istanbul Universitesi Onkoloji Enstitusu" in a lesser frequency.

Most popular intervention types in "Istanbul Universitesi Onkoloji Enstitusu" are "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Epacadostat" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Paclitaxel" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Istanbul Universitesi Onkoloji Enstitusu" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Istanbul Universitesi Onkoloji Enstitusu". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Istanbul Universitesi Onkoloji Enstitusu, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istanbul Universitesi Onkoloji Enstitusu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".